Maternal pertussis (Tdap) vaccination and its effects on the immune response of the new-born up to 12 months of age.

Trial Profile

Maternal pertussis (Tdap) vaccination and its effects on the immune response of the new-born up to 12 months of age.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 May 2015

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Acronyms MIKI
  • Most Recent Events

    • 30 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top